Bloomberg Markets with Carol Massar and Cory Johnson.

GUEST:
Cynthia Koons
Healthcare Reporter 
Bloomberg News 
Discussing Mylan NV facing an increasing backlash over its handling of the EpiPen pricing controversy, as a top proxy adviser urged shareholders to oust the drugmaker’s board.

Bloomberg Markets with Carol Massar and Cory Johnson.

GUEST:
Cynthia Koons
Healthcare Reporter 
Bloomberg News 
Discussing Mylan NV facing an increasing backlash over its handling of the EpiPen pricing controversy, as a top proxy adviser urged shareholders to oust the drugmaker’s board.

Listen for reporting from the magazine that helps global leaders stay ahead. 

Hosts Carol Massar and Tim Stenovec bring you insight on the people, companies and trends shaping today's complex economy.  You can watch and listen to Businessweek LIVE on YouTube, weekdays from 2PM to 5PM ET: http://bit.ly/3vTiACF. 

Listen for reporting from the magazine that helps global leaders stay ahead. Hosts Carol Massar and Tim Stenovec bring you insight on the people, companies and trends shaping today's complex economy.&nbsp; You can watch and listen to Businessweek LIVE on YouTube, weekdays from 2PM to 5PM ET: <a href="http://bit.ly/3vTiACF">http://bit.ly/3vTiACF</a>.&nbsp;

Carol Massar and Tim Stenovec bring together the latest news from the world of business and finance and the interesting stories of global technology, politics, economics and more by harnessing the power of Bloomberg Businessweek reporters and editors.

Bloomberg Businessweek

Bloomberg Markets: Adviser Backs Dumping Mylan Board

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/36f9ec1a-d346-4f1d-8169-ae2b00ffe13a/transcript